DƯỢC LÍ Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th, 2010

Sera N, Ashizawa K, Ando T, et al. Treatment with propylthiouracil
is associated with appearance of antineutrophil cytoplasmic
antibodies in some patients with Graves’ disease.
Thyroid, 2000, 10:595–599.
Silva JE. Thermogenic mechanisms and their hormonal regulation.
Physiol Rev, 2006, 86:435–464.
Simonides WS, Mulcahey MA, Redout EM, et al. Hypoxiainducible
factor induces local thyroid hormone inactivation
during hypoxic-ischemic disease in rats. J Clin Invest, 2008,
118:975–983.
Sipos JA, Shah MH. Thyroid cancer: Emerging role for targeted
therapies. Ther Adv Med Oncol, 2010, 2:3–16.
Smerdely P, Pitsiavas V, Boyages SC. Evidence that the
inhibitory effects of iodide on thyroid cell proliferation are due
to arrest of the cell cycle at G0G1 and G2M phases.
Endocrinology, 1993, 133:2881–2888.
Spencer CA, LoPresti JS. Measuring thyroglobulin and thyroglobulin
antibody in patients with differentiated thyroid cancer.
Nat Clin Pract Endocrinol Metab, 2008, 4:223–233.
St. Germain DL, Galton VA, Hernandez A. Minireview: Defining
the roles of the iodothyronine deiodinases: Current concepts
and challenges. Endocrinology, 2009, 150:1097–1107.
Sunthornthepvarakul T, Gottschalk ME, Hayashi Y, Refetoff S. Brief
report: Resistance to thyrotropin caused by mutations in the
thyrotropin-receptor gene. N Engl J Med, 1995, 332:155–160.
Surks MI, Hollowell JG. Age-specific distribution of serum thyrotropin
and antithyroid antibodies in the US population:
Implications for the prevalence of subclinical hypothyroidism.
J Clin Endocrinol Metab, 2007, 92:4575–4582.
Takami H. Lithium in the preoperative preparation of Graves’
disease. Int Surg, 1994, 79:89–90.
Takasu N, Yamada T, Shimizu Y. Generation of H 2
O 2
is regulated
by cytoplasmic free calcium in cultured porcine thyroid cells.
Biochem Biophys Res Commun, 1987, 148:1527–1532.
Taurog A, Dorris ML, Doerge DR. Mechanism of simultaneous
iodination and coupling catalyzed by thyroid peroxidase. Arch
Biochem Biophys, 1996, 330:24–32.
Tellez RT, Chacon PM, Abarca CR, et al. Long-term environmental
exposure to perchlorate through drinking water and
thyroid function during pregnancy and the neonatal period.
Thyroid, 2006, 15:963–975.
Tonacchera M, Pinchera A, Dimida A, et al. Relative potencies
and additivity of perchlorate, thiocyanate, nitrate, and iodide
on the inhibition of radioactive iodide uptake by the human
sodium iodide symporter. Thyroid, 2004, 14: 1012–1019.
Tuttle RM, Leboeuf R, Martorella AJ. Papillary thyroid cancer:
Monitoring and therapy. Endocrinol Metab Clin North Am,
2007, 36:753–778.
Uy HL, Reasner CA, Samuels MH. Pattern of recovery of the
hypothalamic-pituitary-thyroid axis following radioactive
iodine therapy in patients with Graves’ disease. Am J Med,
1995, 99:173–179.
van Wassenaer AG, Westera J, Houtzager BA, Kok JH. Ten-year
follow-up of children born at <30 weeks’ gestational age supplemented
with thyroxine in the neonatal period in a randomized,
controlled trial. Pediatrics, 2005, 116:e613–618.
Visser WE, Friesema EC, Jansen J, Visser TJ. Thyroid hormone
transport in and out of cells. Trends Endocrinol Metab, 2008,
19:50–56.
Walter MA, Briel M, Christ-Crain M, et al. Effects of anti-thyroid
drugs on radioiodine treatment: Systematic review and metaanalysis
of randomised controlled trials. BMJ, 2007, 334:
514–520.
Wolff J. Perchlorate and the thyroid gland. Pharmacol Rev, 1998,
50:89–105.
Xie J, Pannain S, Pohlenz J, et al. Resistance to thyrotropin
(TSH) in three families is not associated with mutations in the
TSH receptor or TSH. J Clin Endocrinol Metab, 1997,
82:3933–3940.
Yamamoto T, Fukuyama J, Fujiyoshi A. Factors associated with
mortality of myxedema coma: Report of eight cases and literature
survey. Thyroid, 1999, 9:1167–1174.
Yen PM, Ando S, Feng X, et al. Thyroid hormone action at the
cellular, genomic and target gene levels. Mol Cell Endocrinol,
2006, 246:121–127.
Yen PM. Physiological and molecular basis of thyroid hormone
action. Physiol Rev, 2001, 81:1097–1142.
Yoshihara HA, Apriletti JW, Baxter JD, Scanlan TS. Structural
determinants of selective thyromimetics. J Med Chem, 2003,
46:3152–3161.
Zimmerman MB. Iodine deficiency. Endocr Rev, 2009, 30:
376–408.
Zoeller RT, Dowling AL, Vas AA. Developmental exposure to
polychlorinated biphenyls exerts thyroid hormone-like effects
on the expression of RC3/neurogranin and myelin basic protein
messenger ribonucleic acids in the developing rat brain.
Endocrinology, 2000, 141:181–189.
1161
CHAPTER 39
THYROID AND ANTI-THYROID DRUGS